The antimicrobial susceptibility of Stenotrophomonas maltophilia isolates using three different methods and their genetic relatedness

BMC Microbiology

Volumn 5, Issue , 2005, Pages

  Tatman Otkun, Müşerref ^a   Gürcan, Şaban ^a   Özer, Burçin ^a   Aydoslu, Bayram ^a   Bukavaz, Şebnem ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTIINFECTIVE AGENT; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; GENETICS; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; STENOTROPHOMONAS MALTOPHILIA; TECHNIQUE;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; DRUG RESISTANCE, BACTERIAL; PHYLOGENY; STENOTROPHOMONAS MALTOPHILIA;

STENOTROPHOMONAS MALTOPHILIA;

EID: 21844457635     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-5-24     Document Type: Article

References (17)

1. Carroll KC, Cohen S, Nelson R, Campbell DM, Claridge JD, Garrison MW, Kramp J, Malone C, Hoffmann M, Anderson DE: Comparison of various in vitro susceptibility methods for testing Stenotrophomonas maltophilia. Diagn Microbiol Infect Dis 1998, 32:229-235.
2. Denton M, Kerr KG: Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998, 11:57-80.
3. Benian Ö, Alimgil L, Erda N: Two cases of Stenotrophomonas maltophilia endophthalmitis. Ophthalmic Surg Lasers 2002, 33:253-256.
4. Munter RG, Yinnon AM, Schlesinger Y, Hershko C: Infective endocarditis due to Stenotrophomonas (Xanthomonas) maltophilia. Eur J Clin Microbiol Infect Dis 1998, 17:353-356.
5. In vitro activity against Stenotrophomonas maltophilia: Single versus combination agents [http://www.jrnlapplie dresearch.com/articles/Vol3Iss2/ Pendland.htm]
6. Krueger TS, Clark EA, Nix DE: In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations. Diagn Microbiol Infect Dis 2001, 41:71-78.
7. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved Standard. NCCLS Document M7-A6 6th edition. Wayne, Pa, USA; 2003.
8. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests: Approved Standard. NCCLS Document M2-A8 8th edition. Wayne, Pa, USA; 2003.
9. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disc susceptibility testing-fourteen informational supplement M100-S14 Wayne, Pa, USA; 2004.
10. Nicodemo AC, Araujo MRE, Ruiz AS, Gales AC: In vitro susceptibility of Stenotrophomonas maltophilia isolates: Comparison of disc diffusion, Etest and agar dilution methods. J Antimicrob Chemother 2004, 53:604-608.
11. Jorgensen JH: Selection criteria for an antimicrobial susceptibility testing system. J Clin Microbiol 1993, 31:2841-2844.
12. vanCouwenberghe CY, Cohen SH, Tang YJ, Gumerlock PH, Silva JJr: Genomic fingerprinting of epidemic and endemic strains of Stenotrophomonas maltophilia (formerly Xanthomonas maltophilia) by arbitrarily primed PCR. J Clin Microbiol 1995, 33:1289-1291.
13. Yao JDC, Conly JM, Krajden M: Molecular typing of Stenotrophomonas (Xanthomonas) maltophilia by DNA macrorestriction analysis and random amplified polymorphic DNA analysis. J Clin Microbiol 1995, 33:2195-2198.
14. Pankuch GA, Jacobs MR, Rittenhouse SF, Appelbaum PC: Susceptibilities of 123 strains of Xanthomonas maltophilia to eight ß-lactams (including ß-lactam- ß-lactamase inhibitor combinations) and ciprofloxacin tested by five methods. Antimicrob Agents Chemother 1994, 38:2317-2322.
15. Laing FPY, Ramotar K, Read RR, Alfieri N, Kureishi A, Henderson EA, Louie TJ: Molecular epidemiology of Xanthomonas maltophilia colonization and infection in the hospital environment. J Clin Microbiol 1995, 33:513-518.
16. Yao JDC, Louýe M, Louýe L, Goodfellow J, Simor AE: Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenothrophomonas (Xanthomonas) maltophilia. J Clin Microbiol 1995, 33:1428-1430.
17. Valdezate S, Vindel A, Martín-Dávila P, Sánchez del Saz B, Baquero F, Cantón R: High genetic diversity among Stenothrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol 2004, 42:693-699.